This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bioprojet Pharma, Phost'in. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Morgan Pauchet: Innovator in Pharmaceutical Chemistry
Introduction
Morgan Pauchet is a notable inventor based in Mont Saint Aignan, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of various compounds. With a total of 2 patents, Pauchet continues to push the boundaries of pharmaceutical research.
Latest Patents
Morgan Pauchet's latest patents include a polymorph form of pitolisant hydrochloride. This patent relates to a new crystalline form (Form II) of pitolisant hydrochloride, along with pharmaceutical compositions and dosage forms that incorporate this form. The invention also outlines methods for treating diseases or disorders using Form II. Another significant patent is for a crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2λ5-[1,2]oxaphosphinane. This patent describes a novel crystalline polymorphic form and a method for its preparation.
Career Highlights
Throughout his career, Morgan Pauchet has worked with prominent companies in the pharmaceutical industry, including Bioprojet Pharma and Phost'in. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.
Collaborations
Morgan has collaborated with several professionals in his field, including Marc Capet and Ludovic Clarion. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.
Conclusion
Morgan Pauchet is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.